Combination of metformin and rapamycin for treatment of neurological, muscular and proliferative diseases
CN121368477A · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name ALIXIRA PHARMACEUTICALS AG.
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
CN121368477A · Application publication visible